Skip to content

Kodiak Sciences Inc KOD Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$3.17M+47.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$738K+37.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.43M+3.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$13M+8.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$3.89M-34.4%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's operating lease liabilities (current)?
Kodiak Sciences Inc (KOD) reported operating lease liabilities (current) of $11.66M in Q1 2026.
How has Kodiak Sciences Inc's operating lease liabilities (current) changed year-over-year?
Kodiak Sciences Inc's operating lease liabilities (current) increased by 6.5% year-over-year, from $10.95M to $11.66M.
What is the long-term trend for Kodiak Sciences Inc's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's operating lease liabilities (current) has grown at a 38.4% compound annual growth rate (CAGR), from $2.37M to $12.06M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.